Stay updated on Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, indicating a site release rather than a substantive change to the study information.
    Difference
    0.0%
    Check dated 2026-04-23T22:08:44.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    - Revision: v3.5.2 is now shown, replacing the previous Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-16T18:35:57.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    39 days ago
    Change Detected
    Summary
    Revision: v3.5.0 released, replacing the previous v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T20:39:11.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    - Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-11T18:12:38.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    Added site revision note v3.4.2 and removed prior notices about government funding lapse and NIH operating status (v3.4.1).
    Difference
    0.3%
    Check dated 2026-02-11T05:32:24.000Z thumbnail image
  7. Check
    82 days ago
    Change Detected
    Summary
    Added a Results Posted date (2026-01-30) and associated results data for the TROPiCS-03 study across multiple cohorts. Updated the trial design to non-randomized, parallel assignment and expanded cohort descriptions (NSCLC subtypes, HNSCC, EC, ES-SCLC) with revised inclusion criteria and treatment regimens.
    Difference
    5%
    Check dated 2026-02-04T05:36:30.000Z thumbnail image

Stay in the know with updates to Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Sacituzumab Govitecan in Metastatic Solid Tumors Clinical Trial page.